Lentivirus-mediated silencing of HSDL2 suppresses cell proliferation in human gliomas (Q38818624)

6 September 2017

title

Lentivirus-mediated silencing of HSDL2 suppresses cell proliferation in human gliomas (English)

1 reference

6 September 2017

Chen Ruokun

1

1 reference

6 September 2017

Xue Yake

2

1 reference

6 September 2017

Yang Fengdong

3

1 reference

6 September 2017

Wei Xinting

4

1 reference

6 September 2017

Song Laijun

5

1 reference

6 September 2017

Liu Xianzhi

6

1 reference

6 September 2017

publication date

22 September 2016

1 reference

6 September 2017

1 reference

6 September 2017

volume

37

1 reference

6 September 2017

issue

11

1 reference

6 September 2017

page(s)

15065-15077

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-016-5402-6

6 September 2017

exact match

0 references

cites work

The 2007 WHO classification of tumours of the central nervous system

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5402-6

The 2007 Revised World Health Organization (WHO) Classification of Tumours of the Central Nervous System: newly codified entities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5402-6

CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5402-6

21 January 2018

Genetics of adult glioma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5402-6

Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5402-6

Glioblastoma and other malignant gliomas: a clinical review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5402-6

Epidemiology of brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5402-6

Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5402-6

Spatiotemporal Evolution of the Primary Glioblastoma Genome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5402-6

The somatic genomic landscape of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5402-6

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5402-6

Mutational landscape and clonal architecture in grade II and III gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5402-6

Ether-linked glycerolipids in human brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5402-6

Tumorigenicity of cell lines with altered lipid composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5402-6

Ether lipid generating enzyme AGPS alters the balance of structural and signaling lipids to fuel cancer pathogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5402-6

Peroxisomes: a nexus for lipid metabolism and cellular signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5402-6

The proteome of human liver peroxisomes: identification of five new peroxisomal constituents by a label-free quantitative proteomics survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5402-6

Subcellular localization of sterol carrier protein-2 in rat hepatocytes: its primary localization to peroxisomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5402-6

Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5402-6

Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5402-6

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5402-6

AKT/PKB signaling: navigating downstream

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5402-6

Molecular cloning and characterization of a novel human hydroxysteroid dehydrogenase-like 2 (HSDL2) cDNA from fetal brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5402-6

In search for function of two human orphan SDR enzymes: hydroxysteroid dehydrogenase like 2 (HSDL2) and short-chain dehydrogenase/reductase-orphan (SDR-O)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5402-6

The 4th Edition of WHO Classification of Tumours of the Central Nervous System published in 2007

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27658777

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Ether-lipids, -glycerol phosphate dehydrogenase, and growth rate in tumors and cultured cells

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27658777

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Alkyl and alk-1-enyl ethers of glycerol in lipids from normal and neoplastic human tissues

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27658777

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13277-016-5402-6

1 reference

Dimensions Publication ID

6 September 2017

1025696174

0 references

1 reference